ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation
Recruiting
Observational Study
Tricuspid Regurgitation
Heart Failure
Valve Heart Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- Medical University of Warsaw · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to characterize the population of patients qualified for transcatheter tricuspid valve interventions (TTVI). It is expected to:
* Describe the profile of patients qualified for TTVI
* Establish the most common causes for disqualification from TTVI
* Evaluate the immediate and long-term efficacy of TTVI
* Evaluate TTVI safety Participants will undergo a stan…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* tricuspid regurgitation
* qualification for transcatheter tricuspid valve intervention
Exclusion Criteria:
* tricuspid regurgitation qualified for surgical treatment
* concomitant left heart valve disease qualified for surgical treatment
* multivessel coronary artery disease…
Contacts